DCOY Decoy Therapeutics Inc.
Company Analysis
Latest News
🔴 DCOY is trading 7.2% down today as SEC effectiveness clears path for IPO
DCOY is trading 7.2% down at $5.49 after the company received SEC effectiveness for its S-1 registration, clearing the way for its planned IPO and related...
Decoy Therapeutics Clears SEC Hurdle, Paving Way for AI Biotech IPO
Decoy Therapeutics Inc. received a notice of effectiveness from the U.S. Securities and Exchange Commission (SEC) for its S-1 registration statement. This...
🟢 DCOY is trading 8.5% up today in a rebound following a weak session with no clear catalyst
DCOY is trading at $6.51 (+8.50%) in pre-market action, rebounding from a weak prior session despite a lack of fresh company-specific news, earnings, or...
🔴 DCOY is trading 5.9% down today on light, catalyst-free trading
DCOY is trading at $5.92 (-5.90%) in pre-market action on light, catalyst-free trading following a prior session close of $6.30. • No company-specific...
🟢 Decoy Therapeutics Inc. is trading 6.3% up today with no clear catalyst
Decoy Therapeutics Inc. is trading 6.3% up at $6.45 on light, catalyst-free trading so far today. • No fresh company-specific news, filings, analyst calls, or...
🟢 Decoy Therapeutics Inc. is trading 2.4% up today as it rebounds from dilution-driven selloff
Decoy Therapeutics Inc. is trading 2.4% up today at $6.09 as it rebounds from a recent dilution-driven selloff. • The stock faced pressure earlier this week...
🟢 Decoy Therapeutics Inc. is trading 6.5% up today as it rebounds from a dilution-driven selloff
Decoy Therapeutics Inc. is trading at $6.83 (+6.47%) in pre-market as the stock extends a recovery from its June 16 dilution-related decline. • The stock was...
🟢 Decoy Therapeutics Inc. is trading 10.2% up today as it rebounds from a dilution-driven selloff
Decoy Therapeutics Inc. is trading 10.2% up today at $6.48, reversing a portion of yesterday’s losses tied to dilution concerns from a resale filing. • The...
🔴 Decoy Therapeutics Inc. is trading 5.7% down today on 60% dilution risk from share resale filing
Decoy Therapeutics Inc. is trading 5.7% down today at $5.75 after disclosing a share resale filing that raised significant dilution concerns. • The company...
Decoy Therapeutics files for share resale, facing 60% dilution risk
Decoy Therapeutics filed for an offering of up to 808,000 common shares by selling stockholders on June 15, 2026. This follows a June 12 S-1 filing registering...